Indeed, staining for expression of FOXO3A in tissue microarrays of 317 breast cancer patients (characteristics in Table S6) showed that the ∼25% of patients without FOXO3A have a higher recurrence rate in up to 12 years of follow-up (Figure 6). This evidence concerns the gene FOXO3 and breast carcinoma.